Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

‘Heart-in-a-Jar’ Could Save Pharma Companies Billions

The Novoheart is a tiny beating heart-like structure composed of stem cells. It's used for drug testing and is changing the way drugs make it to market.

Novoheart / Image: Novoheart
Novoheart / Image: Novoheart

Taking a drug from initial concept to clinical trial takes about a decade and a billion dollars. A recent CBC News article discussed a new concept: a ‘heart-in-a-jar’ that’s posed to save pharmaceutical companies years of development and a lot of money. The Novoheart is an actual beating heart-like structure made of stem cells that could revolutionize the path to market for new drugs.

Creating the heart valves is a multi-step process where scientists reprogram blood cells into stem cells that are then manipulated into heart cells. Millions of these heart cells form a Jello-O like solution that grows into a mold taking the shape of the “heart.” Once fully formed, the mini heart beats allowing scientists to measure the pace, similar to a heart rate. Pharmaceutical companies have already expressed interest, but Novoheart must file paperwork with the securities regulator before divulging details.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?